Overview: Galactose Levels TestIntroduction: The Galactose Levels Test measures galactose to diagnose galactosemia, a disorder causing developmental delays or liver issues, helping guide dietary management. Affecting 1 in 60,000 newborns, galactosemia poses diagnostic challenges due to early onset. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses enzymatic assay for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, dietary planning, and improving outcomes in pediatrics.
Other Names: Galactose Test, Galactosemia Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Galactose testing began in the 1950s with research by Isselbacher, who linked it to galactosemia. Enzymatic assay advancements in the 1990s by Roche improved detection, surpassing earlier qualitative methods.
Purpose: Measures galactose levels to diagnose galactosemia, guides galactose-free diet, and evaluates patients with developmental delays, aiming to prevent complications.
Test Parameters: Galactose levels
Pretest Condition: Fasting preferred to reflect baseline levels. Collect plasma or urine. Report history of metabolic issues.
Specimen: Plasma (NaHep, 2-4 mL), Urine (sterile container, 5-20 mL); 2 mL plasma in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document developmental delay or liver issues. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., cirrhosis), and sample collection risks.
Procedural Considerations: Uses enzymatic assay to measure galactose, requiring labs with spectrophotometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or non-fasting status can skew results. Medications may not affect results but require correlation.
Clinical Significance: Elevated galactose confirms galactosemia, guiding therapy. Early dietary changes might prevent damage, while untreated cases lead to death. Normal levels may require genetic tests.
Specialist Consultation: Consult a pediatrician or metabolic specialist for interpretation.
Additional Supporting Tests: GALT activity, genetic panel, or liver function test to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with symptoms needed. Fasting variability may affect accuracy.
References: ACMG Guidelines, 2023; Journal of Clinical Investigation, Isselbacher KJ, 2022.
